Elder Pharmaceuticals Ltd - ELDER PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE975A01015
₹ 38.00 (4.97%) icon12 Sep, 2016, 3:28:30 PM
Open
₹ 38.00
Prev. Close
₹ 36.20
Turnover(lac)
₹ 0.00
Day's High
₹ 38.00
Day's Low
₹ 38.00
52 Wk High
₹ 0.00
52 Wk Low
₹ 0.00
Book Value
₹ 382.46
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 78.05
P/E
0.00
EPS
0.00
Div. Yield
0.00

Elder Pharmaceuticals Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 9/12/2016 3:28:30 PM

    ₹ 38 1.80 4.97
  • Open
  • ₹ 38
  • Prev. Close
  • ₹ 36.2
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 38
  • Day's Low
  • ₹ 38
  • 52 Week's High
  • ₹ 0
  • 52 Week's Low
  • ₹ 0
  • Book Value
  • ₹ 382.46
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 78.05
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Elder Pharmaceuticals Ltd Corporate Actions

No Record Found


Elder Pharmaceuticals Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Elder Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT
19 April , 2024 | 09:50 AM

PROMOTER - TOTAL25.34%

Indian: 25.34%

Foreign: 0%

NON-PROMOTER - TOTAL 74.66%

Institutions: 23.98%

Non-Institutions: 50.67%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Elder Pharmaceuticals Ltd FINANCIALS

Elder Pharmaceuticals Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Elder Pharmaceuticals Ltd

  • Alok Jagdish Saxena
  • Managing Director & CEO
  • Edoardo Carlo Richter
  • Director
  • Vijendra Jain
  • Company Secretary
  • Ravani Mohammed Abdul Khader
  • Additional Director
  • Kader Mohammed Davawala
  • Additional Director

Summary

Elder Pharmaceuticals Ltd is one of the fastest growing pharmaceutical companies in India. The companys principal activities include the manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices. They are engaged in the manufacture of a wide range of pharmaceutical product through research and development and also in the manufacturing and marketing of diverse products through licensing agreements with international pharmaceutical companies. They are also engaged in the manufacturing of active pharmaceutical ingredients. Elder Pharmaceuticals Ltd was incorporated on April 2, 1983 in Maharashtra. The company started their commercial activities in the year 1988. In the year 1989, they commissioned their first factory in Navi Mumbai. The company was converted into a public limited company in August 1998. Over the years, the company launched the medicines either through their own research or through alliances with global companies.The company entered into strategic alliances with a number of international pharmaceutical entities for marketing their products in India and overseas international acquisitions have strengthened and enabled the company to become a true-global pharmaceutical company. They made the tie up with Haw Par, Singapore during the year 1994 and Fujisawa during the year 1998.During the year 2000-01, the company entered into joint venture agreement with Stiefel Laboratories Inc. Also they made a tie up with Paul Hartmann of... Read More


Reports by Elder Pharmaceuticals Ltd


Reports by Elder Pharmaceuticals Ltd

Company FAQ

No Record Found